Turn Therapeutics TTRX
NASDAQ TTRX
$10.11 +0.19 (+1.92%)
As of: Nov 11, 2026 · 9:30 AM EST

Turn Therapeutics (TTRX) Net Equity Issued and Repurchased (2024 - 2025)

Updated

Turn Therapeutics (TTRX) recorded Net Equity Issued and Repurchased of $3.18 million in Q4 2025, up 508.5% from $522,206 a year earlier and up 434.4% from the prior quarter.

Analysis

Turn Therapeutics (TTRX) Net Equity Issued and Repurchased (2024 - 2025) Analysis & Trends

For FY2025, Turn Therapeutics reported Net Equity Issued and Repurchased of $6.92 million, up 500.4% from FY2024.

  • Across earlier years, Net Equity Issued and Repurchased came in at $1.15 million in FY2024.
  • Per Business Quant, the preceding three quarters came in at $594,617 (Q3 2025), $2.15 million (Q2 2025) and $998,092 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -377.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -966.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -5.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -406.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -283.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Turn Therapeutics 303.28 Mn 266.54 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 3.77 Mn
Jun 30, 2025 2.15 Mn
Mar 31, 2025 998,092.00
Dec 31, 2024 522,206.00
API Access

Turn Therapeutics Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=TTRX&period=max&api_key=YOUR_API_KEY